Sunitinib vs IMA901 + sunitinib (targeted agent versus tumour vaccine + targeted agent)
Health‐related quality of life6 · Treatment‐naïve metastatic renal cell carcinoma (clear cell type)
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found